Bean Stock Ventures Logo
  • What’s new
  • Services
  • Investments
  • About
  • Careers
  • Contact
  • Blog
Work with us

Quality Regulatory Compliance Updates – 24 July 2020

FDA / EU MDR / Regulatory News

FDA exempts additional Class II devices from 510(k) requirements

The FDA is publishing an order setting forth the Agency’s final determination to exempt a list of class II devices from premarket notification (510(k)) requirements, subject to certain limitations.

The exemption will decrease regulatory burdens on the medical device industry and will eliminate private costs and expenditures required to comply with certain Federal regulations.

This order is effective July 22, 2020.

Table 1—Class II Devices

21 CFR section Device type Exempt product code Non-exempt product code (non-exempt) Partial exemption limitation (if applicable)
884.6120 Accessory, Assisted Reproduction QKH MQG Exemption is limited to assisted reproduction laminar flow workstations.
884.6180 Media, Reproductive QKI MQL Exemption is limited to phosphate-buffered saline used for washing, and short-term handling and manipulation of gametes and embryos; culture oil used as an overlay for culture media containing gametes and embryos; and water for assisted reproduction applications.
888.4505 Instruments Designed for Press-Fit Osteochondral implants Not Applicable QBO Not Applicable.
890.5360 * Interactive Rehabilitation Exercise Devices QKC LXJ Exemption is limited to prescription (Rx) use only.
890.5670 Massager, Therapeutic, to Internally Massage Trigger Points in the Pelvic Floor Musculature QKD OSD Exemption is limited to prescription (Rx) use only devices which incorporate a quantitative feedback mechanism and a disposable covering.
* FDA is revising the name of the device type under product code LXJ from “System, Optical Position/Movement Recording” to “Interactive Rehabilitation Exercise Devices.”

 

US FDA 2020 agenda

The US Food and Drug Administration has identified final rules, guidance and other actions the agency plans to pursue as part of its Spring 2020 Agency Rule List. The agency’s unified agenda includes 26 final rules as well as 52 proposed rules, some of which have been carried over from previous agendas.

It includes:

  • Harmonizing and Modernizing Regulation of Medical Device Quality Systems (The revisions will update the existing requirements with the specifications of an international consensus standard for medical device manufactures, ISO 13485:2016. The revisions are intended to promote the use of more modern risk management principles and reduce regulatory burdens on device manufacturers and importers by harmonizing domestic and international requirements)
  • Medical Devices; Amendments to Medical Device Classification Regulations That Exclude Software Functions In Accordance With the 21st Century Cures Act. Certain medical software functions will be excluded from the definition of device and therefore, where appropriate, will be excluded from FDA regulation as a device:
    • Software Function Intended for Administrative Support of a Health Care Facility
    • Software Function Intended for Maintaining or Encouraging a Healthy Lifestyle
    • Software Function Intended to Serve as Electronic Patient Records (subject to certain limitations)
    • Software Function Intended for Transferring, Storing, Converting Formats, Displaying Data and Results

Cybersecurity

Malicious Activity Targeting COVID-19 Research, Vaccine Development

Western intelligence agencies say they’ve found evidence that malicious cyber actor is targeting efforts to develop a coronavirus vaccinein a number of countries. In an advisory report, the UK’s National Cyber Security Centre (NCSC) said the Russia-linked cyber espionage group commonly known as ‘APT29’ — which is also sometimes referred to as ‘the Dukes’ or ‘Cozy Bear’ — has targeted various organizations involved in medical R&D and COVID-19 vaccine development in Canada, the US and the UK throughout 2020.

Tools include SOREFANG, WELLMESS, and WELLMAIL malware.

US Cybersecurity and Infrastructure Security Agency (CISA) encourages users and administrators to review the Joint Cybersecurity Advisory and the following Malware Analysis Reports for more information and to apply the mitigations provided.

Share

you may also like

Whitepaper: Navigating FDA Cybersecurity Requirements for Medical Devices

Rapid Rise of Digital Health

Whitepaper: The Rapid Rise of Digital Health Technology: Challenges and Keys to Success

Whitepaper: How to Clear a Software Medical Device with the FDA

Quality / Compliance / Regulatory

Quality Regulatory Compliance Updates – 13 November 2020

Quality / Compliance / Regulatory

Quality / Compliance / Regulatory Updates – 23 October 2020

Quality / Compliance / Regulatory

Quality / Compliance / Regulatory Updates – 28 September 2020

Quality / Compliance / Regulatory

Quality / Compliance / Regulatory Updates – 28 August 2020

Quality / Compliance / Regulatory

Quality / Compliance / Regulatory Updates – 7 August 2020

Quality / Compliance / Regulatory

Quality Regulatory Compliance Updates – 24 July 2020

Tips to reduce the risk of a cybersecurity breach

7 Steps Towards Implementing Data Privacy

Product Recalls and Issues

How to Determine if Your Product is a Medical Device

Quality / Compliance / Regulatory

FDA / Regulatory News

Load More
beanstock-logo
made-with-logo

It’s time to take your healthcare products to new heights.

marketing@beanstockventures.com

Company

  • Services
  • Investments
  • About
  • Careers
  • Contact

Services

  • Software Platform
  • Regulatory Resources
  • Regulatory Support Services

© 2025 BeanStock Ventures

Drop your work email to view our BeanStock Ventures Product Portfolio